Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights.
about
3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells.Current management of hepatocellular carcinoma: an Eastern perspective.Novel therapeutic targets and predictive markers for hepatocellular carcinoma.AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma.SAC3D1: a novel prognostic marker in hepatocellular carcinoma
P2860
Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Development of systemic therap ...... at 2013: updates and insights.
@en
type
label
Development of systemic therap ...... at 2013: updates and insights.
@en
prefLabel
Development of systemic therap ...... at 2013: updates and insights.
@en
P2860
P356
P1476
Development of systemic therap ...... at 2013: updates and insights
@en
P2093
Stephen L Chan
Winnie Yeo
P2860
P304
P356
10.3748/WJG.V20.I12.3135
P407
P577
2014-03-01T00:00:00Z